As a result of participating in this activity, learners will be able to: Discuss the role of Combined Modality Therapy for treatment of colorectal Liver metastasis, identify the sequence of Combined Modality Therapy in Liver Metastasis from Rectal cancer, and review indications and Contraindications for HIPEC in Colorectal Carcinomatosis.
The target audience for this presentation: Currently practicing physicians who actively see patients in Oncology, Radiation Oncology, Gastroenterology, and Family Medicine.
This activity has been approved for AMA PRA Category 1 Credit™
View related document for accreditation information.
If you have any questions or credit related inquiries, please contact USF Health at email@example.com